Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Heartburn and CYP2C19[original query] |
|---|
| Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease. Alimentary pharmacology & therapeutics 2011 Jan 33 (2): 213-24. Kinoshita Y, Ashida K, Hongo M, |
| Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the CYP2C Locus. Frontiers in genetics 2022 6 13 869160. Kee Ping Siu, Maggo Simran D S, Kennedy Martin A, Barclay Murray L, Miller Allison L, Lehnert Klaus, Curtis Maurice A, Faull Richard L M, Parker Remai, Chin Paul K |
| [The relationship between genetic polymorphism of CYP2C19 and the efficacy of Helicobacter pylori eradication therapy in children]. Zhonghua er ke za zhi = Chinese journal of pediatrics 2023 6 61 (7): 600-605. L L Luo, B Chen, X L Shu, W Zheng, G Long, M Z Jia |
| Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis. International journal of molecular sciences 2024 4 25 (7): . Paula Soria-Chacartegui, Marcos Navares-Gómez, Francisca Molina-Jiménez, Emilio J Laserna-Mendieta, Laura Arias-González, Pedro Majano, Sergio Casabona, Alfredo J Lucendo, Francisco Abad-Santos, Cecilio Santander, Pablo Zubia |
- Page last reviewed:Feb 1, 2024
- Content source: